Innate Pharma SA Vs. Cellectis SA Industry Stock Comparison

Sell

27

IPHA
Innate Pharma SA

Last Price:

1.45

Seasonality Move:

6.04%

Buy

57

CLLS
Cellectis SA

Last Price:

1.96

Seasonality Move:

2.08%

Sell

27

Innate Pharma SA (IPHA) is a Sell

Is Innate Pharma SA a Buy, Sell or Hold?

The current Innate Pharma SA [IPHA] share price is $1.63. The Score for IPHA is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
IPHA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

Buy

57

Cellectis SA (CLLS) is a Buy

Is Cellectis SA a Buy, Sell or Hold?

The current Cellectis SA [CLLS] share price is $1.87. The Score for CLLS is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
CLLS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

IPHA Stock Price Chart

What is Innate Pharma SA's stock price today?

The Innate Pharma SA share price today is $1.63
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IPHA is experiencing slight buying pressure.

CLLS Stock Price Chart

What is Cellectis SA's stock price today?

The Cellectis SA share price today is $1.87
The current trend is relatively stagnant and CLLS is experiencing slight buying pressure.

IPHA Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.1	Sell
Relative Strength Index (14 RSI):	42.81	Sell
Chaikin Money Flow:	999	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(1.64 - 1.92)	Sell
Bollinger Bands (100):	(1.88 - 2.3)	Sell

CLLS Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.01	Sell
Relative Strength Index (14 RSI):	47.31	Sell
Chaikin Money Flow:	0	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(1.79 - 1.93)	Buy
Bollinger Bands (100):	(1.89 - 2.25)	Sell

IPHA Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	1.6	Buy
20-day SMA:	1.75	Sell
50-day SMA:	1.97	Sell
200-day SMA:	2.3	Sell
8-day EMA:	1.65	Sell
20-day EMA:	1.74	Sell
50-day EMA:	1.91	Sell
200-day EMA:	2.24	Sell

CLLS Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	1.91	Sell
20-day SMA:	1.86	Buy
50-day SMA:	1.98	Sell
200-day SMA:	2.35	Sell
8-day EMA:	1.89	Sell
20-day EMA:	1.89	Sell
50-day EMA:	1.96	Sell
200-day EMA:	2.23	Sell

Innate Pharma SA Earnings Growth & IPHA Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.52 per share, and a decrease next year of $0.00 per share.

Cellectis SA Earnings Growth & CLLS Earnings Dates

Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.79 per share, and a decrease next year of $0.06 per share.

Innate Pharma SA Technical Analysis

	Nov 11	Nov 12	Nov 13	Nov 14	Nov 15	Nov 18	Nov 19	Nov 20	Nov 21	Nov 22
	Nov
	11	12	13	14	15	18	19	20	21	22
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Cellectis SA Technical Analysis

	Nov 11	Nov 12	Nov 13	Nov 14	Nov 15	Nov 18	Nov 19	Nov 20	Nov 21	Nov 22
	Nov
	11	12	13	14	15	18	19	20	21	22
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):